BrightSpring Health Services Net Income
| BTSG Stock | 38.85 0.01 0.03% |
As of the 16th of February 2026, BrightSpring Health shows the Downside Deviation of 2.49, risk adjusted performance of 0.0932, and Mean Deviation of 1.82. BrightSpring Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BrightSpring Health information ratio, as well as the relationship between the potential upside and kurtosis to decide if BrightSpring Health is priced correctly, providing market reflects its regular price of 38.85 per share. Given that BrightSpring Health has jensen alpha of 0.1561, we suggest you to validate BrightSpring Health Services's prevailing market performance to make sure the company can sustain itself at a future point.
BrightSpring Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.7193 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -18.5 M | -19.4 M | |
| Net Loss | -18.5 M | -19.4 M | |
| Net Loss | (0.09) | (0.11) | |
| Net Income Per E B T | 0.47 | 0.62 |
BrightSpring | Net Income | Build AI portfolio with BrightSpring Stock |
The Net Income trend for BrightSpring Health Services offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether BrightSpring Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest BrightSpring Health's Net Income Growth Pattern
Below is the plot of the Net Income of BrightSpring Health Services over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BrightSpring Health financial statement analysis. It represents the amount of money remaining after all of BrightSpring Health Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BrightSpring Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BrightSpring Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (20.52 M) | 10 Years Trend |
|
Net Income |
| Timeline |
BrightSpring Net Income Regression Statistics
| Arithmetic Mean | (19,426,905) | |
| Coefficient Of Variation | (222.70) | |
| Mean Deviation | 26,189,445 | |
| Median | (7,621,000) | |
| Standard Deviation | 43,264,246 | |
| Sample Variance | 1871.8T | |
| Range | 204.4M | |
| R-Value | (0.27) | |
| Mean Square Error | 1847.8T | |
| R-Squared | 0.07 | |
| Significance | 0.29 | |
| Slope | (2,339,123) | |
| Total Sum of Squares | 29948.7T |
BrightSpring Net Income History
Other Fundumenentals of BrightSpring Health
BrightSpring Health Net Income component correlations
BrightSpring Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for BrightSpring Health is extremely important. It helps to project a fair market value of BrightSpring Stock properly, considering its historical fundamentals such as Net Income. Since BrightSpring Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BrightSpring Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BrightSpring Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Health Care Providers & Services industry sustain growth momentum? Does BrightSpring have expansion opportunities? Factors like these will boost the valuation of BrightSpring Health. Projected growth potential of BrightSpring fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating BrightSpring Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.383 | Earnings Share 0.54 | Revenue Per Share | Quarterly Revenue Growth 0.282 | Return On Assets |
Investors evaluate BrightSpring Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BrightSpring Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause BrightSpring Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between BrightSpring Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BrightSpring Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BrightSpring Health's market price signifies the transaction level at which participants voluntarily complete trades.
BrightSpring Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BrightSpring Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BrightSpring Health.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in BrightSpring Health on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding BrightSpring Health Services or generate 0.0% return on investment in BrightSpring Health over 90 days. BrightSpring Health is related to or competes with BioAffinity Technologies, Artelo Biosciences, Revelation Biosciences, WORK Medical, GT Biopharma, Psyence Biomedical, and Protagenic Therapeutics. BrightSpring Health is entity of United States More
BrightSpring Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BrightSpring Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BrightSpring Health Services upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.49 | |||
| Information Ratio | 0.0772 | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 3.44 |
BrightSpring Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BrightSpring Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BrightSpring Health's standard deviation. In reality, there are many statistical measures that can use BrightSpring Health historical prices to predict the future BrightSpring Health's volatility.| Risk Adjusted Performance | 0.0932 | |||
| Jensen Alpha | 0.1561 | |||
| Total Risk Alpha | 0.0667 | |||
| Sortino Ratio | 0.0716 | |||
| Treynor Ratio | 0.1737 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BrightSpring Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BrightSpring Health February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0932 | |||
| Market Risk Adjusted Performance | 0.1837 | |||
| Mean Deviation | 1.82 | |||
| Semi Deviation | 2.2 | |||
| Downside Deviation | 2.49 | |||
| Coefficient Of Variation | 930.31 | |||
| Standard Deviation | 2.31 | |||
| Variance | 5.34 | |||
| Information Ratio | 0.0772 | |||
| Jensen Alpha | 0.1561 | |||
| Total Risk Alpha | 0.0667 | |||
| Sortino Ratio | 0.0716 | |||
| Treynor Ratio | 0.1737 | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 3.44 | |||
| Downside Variance | 6.21 | |||
| Semi Variance | 4.83 | |||
| Expected Short fall | (1.86) | |||
| Skewness | (0.46) | |||
| Kurtosis | 0.1972 |
BrightSpring Health Backtested Returns
BrightSpring Health appears to be very steady, given 3 months investment horizon. BrightSpring Health secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BrightSpring Health Services, which you can use to evaluate the volatility of the firm. Please makes use of BrightSpring Health's Risk Adjusted Performance of 0.0932, downside deviation of 2.49, and Mean Deviation of 1.82 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BrightSpring Health holds a performance score of 12. The firm shows a Beta (market volatility) of 1.37, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BrightSpring Health will likely underperform. Please check BrightSpring Health's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether BrightSpring Health's price patterns will revert.
Auto-correlation | -0.23 |
Weak reverse predictability
BrightSpring Health Services has weak reverse predictability. Overlapping area represents the amount of predictability between BrightSpring Health time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BrightSpring Health price movement. The serial correlation of -0.23 indicates that over 23.0% of current BrightSpring Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
BrightSpring Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, BrightSpring Health Services reported net income of (20.52 Million). This is 106.01% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.59% higher than that of the company.
BrightSpring Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BrightSpring Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BrightSpring Health could also be used in its relative valuation, which is a method of valuing BrightSpring Health by comparing valuation metrics of similar companies.BrightSpring Health is currently under evaluation in net income category among its peers.
BrightSpring Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BrightSpring Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BrightSpring Health's managers, analysts, and investors.Environmental | Governance | Social |
BrightSpring Fundamentals
| Return On Equity | 0.0628 | ||||
| Return On Asset | 0.0497 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 9.57 B | ||||
| Shares Outstanding | 180.35 M | ||||
| Shares Owned By Insiders | 3.15 % | ||||
| Shares Owned By Institutions | 96.84 % | ||||
| Number Of Shares Shorted | 8.25 M | ||||
| Price To Book | 3.85 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 11.27 B | ||||
| Gross Profit | 1.77 B | ||||
| EBITDA | 398.13 M | ||||
| Net Income | (20.52 M) | ||||
| Total Debt | 2.9 B | ||||
| Book Value Per Share | 8.79 X | ||||
| Cash Flow From Operations | 23.77 M | ||||
| Short Ratio | 5.05 X | ||||
| Earnings Per Share | 0.54 X | ||||
| Target Price | 44.47 | ||||
| Number Of Employees | 37 K | ||||
| Beta | 2.38 | ||||
| Market Capitalization | 7.01 B | ||||
| Total Asset | 5.93 B | ||||
| Retained Earnings | (222.16 M) | ||||
| Working Capital | 464.72 M | ||||
| Net Asset | 5.93 B |
About BrightSpring Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BrightSpring Health Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BrightSpring Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BrightSpring Health Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Can Health Care Providers & Services industry sustain growth momentum? Does BrightSpring have expansion opportunities? Factors like these will boost the valuation of BrightSpring Health. Projected growth potential of BrightSpring fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating BrightSpring Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.383 | Earnings Share 0.54 | Revenue Per Share | Quarterly Revenue Growth 0.282 | Return On Assets |
Investors evaluate BrightSpring Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BrightSpring Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause BrightSpring Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between BrightSpring Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BrightSpring Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BrightSpring Health's market price signifies the transaction level at which participants voluntarily complete trades.